Paper Details 
Original Abstract of the Article :
PURPOSE: To compare various characteristics of Xalatan METHODS: Drop size, volume, pH values, buffer capacity, viscosity, hardness of bottles and costs were determined. Drop sizes were measured in triplicates by micropipettes, and the number of drops counted in three separate bottles of each generi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/aos.13355

データ提供:米国国立医学図書館(NLM)

The Importance of Quality Control in Generic Latanoprost Ophthalmic Solutions

This research delves into the crucial area of [pharmaceutical quality] and highlights the need for stringent standards in the development of [generic medications]. The study compares various characteristics of [Xalatan], the original brand version of [latanoprost ophthalmic solutions], to several [generic products]. The authors identified significant differences in [drop size], [volume], [pH values], [buffer capacity], [viscosity], and [bottle hardness] between the [generic] and [brand] versions. These findings suggest that the [generic] products may not be identical to the [original brand] version, raising concerns about [compliance] and potential impact on [intraocular pressure (IOP)]-lowering effect.

Quality Control and Generic Medications

This research emphasizes the importance of maintaining [pharmaceutical quality] in the development of [generic medications]. The findings highlight the need for rigorous [quality control] measures to ensure that [generic products] meet the same standards as their [brand name] counterparts.

Implications for Ophthalmic Medications

This study has significant implications for the [ophthalmic medication] industry. The findings underscore the need for reevaluation of [regulations] and [quality control] standards for [generic eye drops]. Ensuring [quality] and [equivalence] of [generic medications] is critical for patient safety and effective treatment.

Dr. Camel's Conclusion

This study is like a desert traveler who discovers that a seemingly identical path is actually a mirage. Just as a traveler needs to carefully choose their route, patients should be aware of potential differences in [quality] between [generic] and [brand] versions of [medications], particularly when it comes to their [eye health].

Date :
  1. Date Completed 2017-09-29
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

28229536

DOI: Digital Object Identifier

10.1111/aos.13355

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.